2022
DOI: 10.1016/j.lanwpc.2022.100433
|View full text |Cite
|
Sign up to set email alerts
|

Prevention of bacterial complications of scabies using mass drug administration: A population-based, before-after trial in Fiji, 2018–2020

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
11
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 8 publications
(11 citation statements)
references
References 31 publications
0
11
0
Order By: Relevance
“…If parents selected more than one ethnicity, we determined a ‘prioritised’ ethnicity for analysis, consistent with standard practice in the New Zealand health sector 7 …”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…If parents selected more than one ethnicity, we determined a ‘prioritised’ ethnicity for analysis, consistent with standard practice in the New Zealand health sector 7 …”
Section: Methodsmentioning
confidence: 99%
“…A general practitioner conducted the screening procedures after training and testing from an experienced Paediatrician (DE), with expertise in the diagnosis of scabies. Training was based on programmes used in several previous studies 7–9 . Skin lesions were classified by appearance as either typical scabies, atypical for scabies or inconsistent with scabies, according to global consensus definitions (2020 IACS criteria) 10 .…”
Section: Methodsmentioning
confidence: 99%
“…Although the population of LIP has access to high-quality healthcare, the scabies IR remained relatively stable in the province over the study period. This finding suggests that more drastic public health measures are needed to reduce the burden of scabies and associated SSTIs in LIP [30][31][32]. According to a recent WHO framework for scabies control [33,34], ivermectin-based mass drug administration (MDA) should be initiated in areas with a community prevalence �10% or a prevalence in school children � 15% (as measured using a school mapping strategy) and should be avoided in those with a community prevalence <2%.…”
Section: Plos Neglected Tropical Diseasesmentioning
confidence: 99%
“…These are major health burdens in the global south, with sequelae including glomerulonephritis, rheumatic fever and chronic kidney disease. 1 , 2 , 3 In a major step forward Li Jun Thean and colleagues 4 report in The Lancet Regional Health Western Pacific on the impact on skin infections of an oral ivermectin MDA targeting scabies in Fiji. Importantly, they show in the largest before-after trial of its kind that not only did scabies and impetigo prevalence reduce, but so too did hospitalisations with severe skin and soft tissue infections and attendance at primary care with scabies and skin infections.…”
mentioning
confidence: 99%
“…Against this regional and global background Thean and colleagues 4 report a 2018–2020 before-after MDA trial covering Fiji's Northern Division: first dose, 135,744 people (97% coverage); second dose, 121,760 people (87%). The prior MDA in Fiji had 716 participants enrolled in the ivermectin arm, 14 in the Solomon Islands 26,188.…”
mentioning
confidence: 99%